+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

KOMBIGLYZE XR Drug Profile, 2019

  • ID: 4726893
  • Report
  • April 2020
  • Region: Global
  • 42 pages
  • thinkBiotech LLC
1 of 4
KOMBIGLYZE XR Drug Profile, 2019 is part of a deep library of business intelligence on biopharmaceutical drugs.

The report focuses on KOMBIGLYZE XR and covers the following critical aspects of this drug:
  • United States patents
  • FDA Paragraph IV patent challenges
  • District Court patent litigation
  • Patent Trial and Appeal Board (PTAB) patent cases
  • European supplementatry protection certificates (SPCs)
  • Clinical trials
  • Drug prices
  • Finished product suppliers
About the Researcher

The researcher is a provider of global business intelligence on biologic and small-molecule drugs, dedicated to helping clients make better decisions. Critical information on global drug patents is incorporated with litigation intelligence, drug prices, and historic sales figures to help users discover commercial opportunities and forecast future revenue events. Since 2005 the researcher has served hundreds of large and small companies in more than 65 countries.
Note: Product cover images may vary from those shown
2 of 4
  • Profile for KOMBIGLYZE XR
  • US Patents
  • US Regulatory Exclusivity
  • Paragraph IV Patent Challenges
  • US District Court Litigation
  • US Patent Trial and Appeal Board Cases
  • International (ex US) Patents
  • Supplementary Protection Certificates
  • Clinical Trials
  • Drug Prices - Average Pharmacy Cost
  • Finished Product Suppliers
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Astrazeneca Pharmaceuticals Lp
Note: Product cover images may vary from those shown
Adroll
adroll